dendron


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia, Wikipedia.
Related to dendron: axon

dendrite

 [den´drīt]
any of the threadlike extensions of the cytoplasm of a neuron; they typically branch into treelike processes, and compose most of the receptive surface of a neuron.
Dendrites in a multipolar neuron. From Dorland's, 2000.

den·drite

(den'drīt),
1. One of the two types of branching protoplasmic processes of the nerve cell (the other being the axon). Synonym(s): dendritic process, dendron, neurodendrite, neurodendron
2. A crystalline treelike structure formed during the freezing of an alloy.
[G. dendritēs, relating to a tree]

dendron

/den·dron/ (den´dron) dendrite.

dendron

(dĕn′drŏn′)
n.

den·drite

(den'drīt)
1. One of the two types of branching protoplasmic processes of the nerve cell (the other being the axon).
Synonym(s): dendritic process, dendron, neurodendrite.
2. A crystalline treelike structure formed during the freezing of an alloy.
[G. dendritēs, relating to a tree]

dendron

See DENDRITE.

dendron

see DENDRITE.

dendron

dendrite.
References in periodicals archive ?
A new family of liquid crystalline columnar polyethers was obtained by modification of P(ECH-co-EO) with the dendron 3,4,5-tris[4-(n-dodecan-1-yloxy)benzyloxy]ben-zoate.
The introduction of dendrons into the P(ECH-co-E0) is expected to greatly modify the hydrodynamic volume of the system.
This suggests that the presence of the side dendrons, which are responsible for the mesogenic columnar ordering, is also able to induce some crystalline order in the copolymer main chain.
3 million charge for the acquired in-process research and development projects of Dendron, and a $7.
5 million in the 2001 fourth quarter, due primarily to the commencement of the agreement with ev3 International under which the company pays ev3 International fees for sales, marketing and administrative services that did not exist in 2001, increased training and proctoring of physicians in Europe and general and administrative expenses incurred by Dendron during the quarter.
The purpose of the private placement was to support the anticipated short-term working capital needs of MTI's combined operations, and to replenish MTI's cash reserves after MTI made the initial payment with respect to MTI's October 2002 acquisition of German-based Dendron GmbH, a developer and manufacturer of neurovascular focused products, such as embolic coils, for the treatment of brain aneurysms.
Such potential risks and uncertainties include, but are not limited to, the ability to efficiently integrate the operations of Dendron GmbH into those of Micro Therapeutics, Inc.
Such potential risks and uncertainties relate, but are not limited, to, in no particular order: successful completion of the second stage of the private placement of the Company's common stock on a timely basis or at all, integration of the operations of Dendron GmbH into those of Micro Therapeutics, Inc.
MTI's liquid embolic material, Onyx(R), and detachable coils designed and manufactured by its newly acquired subsidiary, Dendron, have been developed for use in the treatment of cerebral vascular conditions that, if left untreated, can lead to stroke.
MTI recently announced that it completed the acquisition of Dendron GmbH, a privately held, German-based developer and manufacturer of neurovascular focused products such as embolic coils for the treatment of brain aneurysms, for approximately $25 million plus additional payments of up to $15 million contingent upon achieving certain revenue targets for Dendron's products.